What is Mendel?
Founded in 2016, Mendel operates at the intersection of deep learning and clinical informatics. The company provides an sophisticated AI engine capable of scanning, interpreting, and structuring vast quantities of unstructured patient data. By transforming fragmented medical records into actionable insights, Mendel enables healthcare providers to deliver highly personalized care plans, thereby improving patient outcomes and operational efficiency. Its market position is defined by its ability to bridge the gap between raw clinical documentation and high-level medical decision support, a critical requirement for modern health systems navigating the complexities of value-based care.
How much funding has Mendel raised?
Mendel has raised a total of $42.1M across 3 funding rounds:
Other Financing Round
$2M
Debt
$150K
Series B
$40M
Other Financing Round (2017): $2M with participation from BootstrapLabs, SOSV, DCM Ventures, and LaunchCapital
Debt (2020): $150K led by PPP
Series B (2022): $40M supported by Oak HC/FT and DCM Limited
Key Investors in Mendel
Oak HC/FT
A premier venture growth-equity fund specializing in Healthcare Information and Services, providing strategic counsel and board-level expertise to transformative companies.
BootstrapLabs
A Silicon Valley-based venture capital firm focused on Applied Artificial Intelligence, acting as a lead investor for mission-driven founders solving high-value global challenges.
LaunchCapital
A venture capital firm dedicated to supporting seed and early-stage entrepreneurs with hands-on assistance and growth capital across diverse industries.
What's next for Mendel?
With the recent influx of capital, Mendel is well-positioned to scale its enterprise-level operations and expand its footprint within the healthcare sector. The strategic focus will likely center on enhancing the predictive capabilities of its AI engine and deepening integrations with existing electronic health record (EHR) infrastructures. As the demand for data-driven clinical intelligence continues to rise, Mendel is poised to leverage its technical moat to capture a larger share of the healthtech market, potentially exploring new therapeutic areas or expanding its service offerings to include broader population health management tools. The company remains a key entity to watch as it continues to refine its algorithmic precision and broaden its impact on clinical workflows.
See full Mendel company page
